Saturday, October 3, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· March 9, 2026

Tech stocks today: OpenAI's robotics leader resigns after Pentagon deal, Anthropic prepares to battle ban

View original at finance.yahoo.com
Tech stocks today: OpenAI's robotics leader resigns after Pentagon deal, Anthropic prepares to battle ban Anthropic (ANTH.PVT) continued to clash with the Defense Department after the artificial intelligence startup was notified that it was designated a "supply chain risk for national security" by the US government…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Small amounts of H200 products for China-based customers were approved by US government but Nvidia has yet to generate any revenue and doesn't know whether imports will be allowed into China

    80% confidence
  • CPUs are growing but GPUs are not slowing down because there's more and more workloads

    80% confidence
  • Nvidia will invest $30 billion in OpenAI and this will likely be the last investment opportunity before OpenAI goes public

    80% confidence
  • Autonomous vehicles and robotaxis will be the most significant change agent in the Auto 2.0 landscape with Tesla at the forefront

    80% confidence
  • Monday was Anthropic's largest single day for sign-ups ever

    80% confidence
  • Broadcom achieved record first quarter revenue on continued strength in AI semiconductor solutions, with Q1 AI revenue of $8.4 billion growing 106% year over year

    80% confidence
  • Nvidia's $10 billion investment in Anthropic will probably be the last

    80% confidence
  • MacBook Neo is one of the most important announcements for Apple in the Mac product line and represents a shift in the history of the Mac

    80% confidence
  • AI revenue growth is accelerating and company anticipates Q2 segment revenue of $10.7 billion

    80% confidence
  • The promise of prediction markets is to harness the wisdom of the crowd to create accurate, unbiased forecasts for the most important events to society

    80% confidence
  • Tesla is the current leader in consumer autonomy and will quickly become a leader in robotaxi services given its ability to scale more profitably than competitors

    80% confidence
  • Anthropic has no choice but to challenge the supply chain risk designation in court

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com